<DOC>
	<DOCNO>NCT02194348</DOCNO>
	<brief_summary>The objective present study obtain information safety , tolerability pharmacokinetics BIBN 4096 BS single subcutaneous administration increase dos healthy male female volunteer</brief_summary>
	<brief_title>Study Determine Tolerability Single Increasing Dose BIBN 4096 BS Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<criteria>Participants healthy male female Age range 21 50 year Broca Index : within 20 % normal weight All female volunteer must use safe contraception ( i.e . oral contraception , spiral , sterilize ) All female volunteer must negative pregnancy test Prior admission treatment give his/her inform consent ( accordance Good Clinical Practice ( GCP ) local legislation ) writing subject medical history take receive complete medical examination ( incl . blood pressure pulse rate measurement ) well 12lead ECG within 14 day administration test substance . Hematopoietic , hepatic renal function test carry laboratory . The subject fast 12 hour collection specimens laboratory evaluation Any find medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; = 24 hour ) within ten halflives respective drug enrolment study study Use drug might influence result trial within two week prior administration trial Participation another study investigational drug within two month prior administration trial Smoker ( &gt; 10 cigarette 3 cigar 3 pipes/day ) Inability refrain smoke study day Alcohol abuse ( &gt; 40g/day ) Drug abuse Blood donation ( &gt; = 100 ml ) within four week prior administration trial Excessive physical activity within five day prior administration trial Any laboratory value outside reference range clinical relevance For female subject : Pregnancy Positive pregnancy test No adequate contraception e.g . oral contraceptive , sterilization , intrauterine pessary ( IUP ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>